Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kaiser

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
The Lancet. Haematology|March 28, 2020
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trialMaria-Victoria Mateos, Hareth Nahi, Wojciech Legiec, et al.
Human Genomics|August 21, 2019
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genesMolly Went, Ben Kinnersley, Amit Sud, et al.
Blood|May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myelomaMeletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Leukemia|May 4, 2018
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma NetworkHeinz Ludwig, Michel Delforge, Thierry Facon, et al.
Hemasphere|October 15, 2025
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myelomaNiccolò Bolli, Mattia D'Agostino, Tina Bagratuni, et al.
Blood Advances|September 27, 2018
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosisJulie Støve Bødker, Rasmus Froberg Brøndum, Alexander Schmitz, et al.
The British Journal of Radiology|June 10, 2025
An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI studySam Keaveney, Damien J McHugh, Mihaela Rata, et al.
Nature Reviews. Clinical Oncology|July 7, 2025
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myelomaMeletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, et al.
Nature Communications|January 11, 2022
Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.
The Lancet. Haematology|June 28, 2025
Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma NetworkNiels W C J van de Donk, Philippe Moreau, Jesús F San-Miguel, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
The Lancet. Haematology|March 28, 2020
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trialMaria-Victoria Mateos, Hareth Nahi, Wojciech Legiec, et al.
Human Genomics|August 21, 2019
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genesMolly Went, Ben Kinnersley, Amit Sud, et al.
Blood|May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myelomaMeletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Leukemia|May 4, 2018
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma NetworkHeinz Ludwig, Michel Delforge, Thierry Facon, et al.
Hemasphere|October 15, 2025
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myelomaNiccolò Bolli, Mattia D'Agostino, Tina Bagratuni, et al.
Blood Advances|September 27, 2018
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosisJulie Støve Bødker, Rasmus Froberg Brøndum, Alexander Schmitz, et al.
The British Journal of Radiology|June 10, 2025
An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI studySam Keaveney, Damien J McHugh, Mihaela Rata, et al.
Nature Reviews. Clinical Oncology|July 7, 2025
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myelomaMeletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, et al.
Nature Communications|January 11, 2022
Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.
The Lancet. Haematology|June 28, 2025
Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma NetworkNiels W C J van de Donk, Philippe Moreau, Jesús F San-Miguel, et al.
Pageof 16